All topics
Six pillars, and everything underneath them.
The pillars are how we organise the newsroom. The topics and tags below are how the reporting actually connects — a single ibogaine piece belongs to psychedelic therapies, addiction treatment, and medical travel at once.
The six pillars
Medical Breakthroughs
New research, emerging treatments, and clinical advances as they move from trial to practice.
4 pieces
We cover new research the way a careful clinician reads it: mechanism first, then trial design, then effect size, then who was actually studied.
ii.Alternative Medicine
Naturopathic, functional, and integrative approaches examined on their own terms.
6 pieces
Naturopathic, functional, and integrative practice is where a great deal of real patient experience lives and where a great deal of unearned confidence lives too.
iii.Energy & Vibrational Healing
Energy work, frequency and sound therapy, light — what is measured and what is claimed.
2 pieces
Energy work, sound, frequency, and light span everything from measurable photobiomodulation to claims with no physical basis.
iv.Psychedelic Therapies
Psilocybin, ketamine, ibogaine and MDMA: mechanism, trial status, and honest limits.
3 pieces
Psilocybin, ketamine, MDMA, and ibogaine are moving through regulatory pipelines at very different speeds, under very different safety profiles.
v.Chronic & Complex Illness
Long-form reporting on Lyme, autoimmunity, long COVID, and contested diagnoses.
2 pieces
Contested and complex illness — Lyme, autoimmunity, long COVID, ME/CFS — is where patients are most often failed and most often sold to.
vi.Clinics & Destinations
Profiles of the treatment centers doing frontier and integrative work, and how they operate.
4 pieces
Clinic reporting is the easiest place to slide into either advertising or ridicule.
Second-tier topics
More depth, without a crowded masthead.
Nutrition & Metabolic Science
Glucose regulation, insulin resistance, metabolic testing, and the diet claims that outrun their data.
Sleep & Circadian Medicine
Light timing, shift work, sleep architecture, and what circadian biology can and cannot explain.
Longevity & Aging Research
Biological age markers, senolytics, caloric restriction, and the distance between mice and people.
Mental Health & Neuroscience
Depression, PTSD, neuromodulation, and the mechanisms behind treatments that work before we know why.
Women's & Hormonal Health
Menopause care, thyroid and adrenal claims, and decades of under-representation in trial populations.
Pediatric & Maternal Medicine
Early-life development, perinatal care, and the evidence standards children's medicine demands.
Environmental & Toxin Exposure
Mold, heavy metals, microplastics, and air quality: exposure science versus detox marketing.
Medical Technology & AI Diagnostics
Imaging models, wearables, and diagnostic algorithms — validation sets, drift, and clinical reality.
Fitness & Physical Recovery Science
Load management, cold and heat exposure, hyperbaric oxygen, and recovery protocols under scrutiny.
Global Health & Policy
Access, regulation, medical travel, and how policy decides which treatments patients can reach.
Full tag index
Narrow it precisely.
- Mental Health & Neuroscience6
- Clinical Trials5
- Cost & Access5
- Medical Travel5
- Biomarker Testing4
- Fitness & Physical Recovery Science4
- Lyme Disease4
- Nutrition & Metabolic Science4
- Placebo & Expectation4
- Regulation4
- Depression3
- Functional Medicine3
- Hyperthermia3
- Science Communication3
- Addiction Treatment2
- Antibiotics2
- Global Health & Policy2
- Ibogaine2
- Integrative Oncology2
- Nervous System2
- PTSD2
- Supplements2
- Acupuncture1
- Chronic Pain1
- Cold Exposure1
- Environmental & Toxin Exposure1
- Hyperbaric Oxygen1
- Ketamine1
- Light Therapy1
- Longevity & Aging Research1
- Meditation1
- Microbiome1
- Neuromodulation1
- Psilocybin1
- Sleep & Circadian Medicine1
- Sound Therapy1
- Wearables & CGM1
The dispatch
Join our list — new writing on the frontier of medicine, in your inbox.
Considered emails, never more than you want. Research, clinics, and what the evidence currently supports. No hype, no unsubscribing guilt.